Ghost Tree Capital, LLC Portfolio Holdings

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Ghost Tree Capital, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $267 Million distributed in 54 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Sarepta Therapeutics, Inc. with a value of $15M, Novo Nordisk A S with a value of $13.1M, Blueprint Medicines Corp with a value of $12.9M, Axsome Therapeutics, Inc. with a value of $12.1M, and Tarsus Pharmaceuticals, Inc. with a value of $11.5M.

Examining the 13F form we can see an increase of $21.8M in the current position value, from $245M to 267M.

Ghost Tree Capital, LLC is based out at New York, NY

Below you can find more details about Ghost Tree Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $267 Million
Healthcare: $237 Million
ETFs: $29.6 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$10.4B
$15 Million 5.62% of portfolio
120,000
Q3 2024 Added 118.18%
$192B
$13.1 Million 4.91% of portfolio
110,000
Q3 2024 New
$5.38B
$12.9 Million 4.85% of portfolio
140,000
Q3 2024 Added 250.0%
$3.89B
$12.1 Million 4.54% of portfolio
135,000
Q3 2024 Reduced 10.0%
$1.41B
$11.5 Million 4.31% of portfolio
350,000
Q3 2024 Added 48.94%
$8.15B
$9.23 Million 3.46% of portfolio
800,000
Q3 2024 Reduced 20.0%
$5.13B
$9.13 Million 3.42% of portfolio
80,000
Q3 2024 Reduced 46.67%
$3.24B
$8.86 Million 3.32% of portfolio
140,000
Q3 2024 Added 47.37%
$740M
$8.66 Million 3.25% of portfolio
450,000
Q3 2024 Added 28.57%
$2.37B
$8.63 Million 3.23% of portfolio
190,000
Q3 2024 Added 280.0%
$7.61B
$7.84 Million 2.94% of portfolio
52,500
Q3 2024 Reduced 39.46%
$2.88B
$7.66 Million 2.87% of portfolio
150,000
Q3 2024 Reduced 37.5%
$4.68B
$7.25 Million 2.72% of portfolio
310,000
Q3 2024 Reduced 38.0%
$166M
$7.15 Million 2.68% of portfolio
1,474,995
Q3 2024 Added 3.76%
$292M
$6.78 Million 2.54% of portfolio
375,000
Q3 2024 Reduced 37.5%
$1.89B
$6.47 Million 2.43% of portfolio
128,411
Q3 2024 Reduced 57.2%
$3.55B
$5.91 Million 2.22% of portfolio
215,000
Q3 2024 Reduced 17.31%
$9.54B
$5.48 Million 2.05% of portfolio
75,000
Q3 2024 Added 15.38%
$1.94B
$5.2 Million 1.95% of portfolio
195,000
Q3 2024 New
$616M
$4.93 Million 1.85% of portfolio
450,000
Q2 2024 Reduced 30.77%
$3.93B
$4.46 Million 1.67% of portfolio
175,000
Q3 2024 Added 25.0%
$89.5M
$4.32 Million 1.62% of portfolio
2,150,000
Q3 2024 Added 72.0%
$3.07B
$4.13 Million 1.55% of portfolio
78,842
Q3 2024 Reduced 32.84%
$249M
$3.85 Million 1.44% of portfolio
650,000
Q3 2024 Added 109.68%
$1.24B
$3.59 Million 1.35% of portfolio
100,000
Q3 2024 New
$983M
$3.57 Million 1.34% of portfolio
145,000
Q3 2024 Added 93.33%
$582M
$3.1 Million 1.16% of portfolio
1,350,000
Q3 2024 Added 17.39%
$368M
$3.07 Million 1.15% of portfolio
725,000
Q3 2024 Reduced 31.01%
$69.1M
$2.9 Million 1.08% of portfolio
1,500,000
Q3 2024 Added 11.11%
$329M
$2.78 Million 1.04% of portfolio
265,000
Q3 2024 Added 55.88%
$232M
$2.64 Million 0.99% of portfolio
500,000
Q3 2024 New
$278M
$2.1 Million 0.79% of portfolio
550,000
Q3 2024 New
$318M
$1.9 Million 0.71% of portfolio
125,000
Q3 2024 New
$3.65B
$1.87 Million 0.7% of portfolio
65,000
Q3 2024 Reduced 51.85%
$3.6B
$1.86 Million 0.7% of portfolio
85,000
Q3 2024 New
$759M
$1.71 Million 0.64% of portfolio
75,000
Q3 2024 Reduced 87.24%
$188M
$1.62 Million 0.61% of portfolio
887,700
Q3 2024 Reduced 1.37%
$53.2M
$1.49 Million 0.56% of portfolio
800,000
Q2 2024 Added 33.33%
$174M
$1.31 Million 0.49% of portfolio
200,000
Q3 2024 New
$235M
$1.05 Million 0.39% of portfolio
325,000
Q3 2024 New
Engene Holdings Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 61.72%
Corbus Pharmaceuticals Hldgs
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 8.57%
Spyre Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 76.02%
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 50.0%
Korro Bio Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 10.0%
Biohaven LTD
-
$0 0.0% of portfolio
-
Q3 2024 New
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 3.85%
Neurogene Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 28.57%
Perspective Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 18.92%

Summary

  • Portfolio
  • No. of Stocks 54
  • Current Value $267 Million
  • Prior Value $245 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 10 stocks
  • Additional Purchases 16 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 22 stocks
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email